Correlation Between Vitamin D Status and Bone Mineral Density in Patients With Hemophilia
1 other identifier
interventional
20
1 country
1
Brief Summary
Study will look at baseline Vitamin D levels, calcium, albumin, liver enzymes, testosterone, osteocalcin, urine N telopeptides, bone mineral density, nutritional assessment and physical activity assessment of boys with hemophilia A or B (ages 2-20 yrs). Patients with low vitamin D levels will receive therapeutic doses of Vitamin D. At end of one year follow up studies will be repeated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 16, 2010
CompletedFirst Posted
Study publicly available on registry
March 19, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedApril 29, 2016
April 1, 2016
3 years
March 16, 2010
April 27, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlate between Vitamin D deficiency, low bone mass and lack of weight bearing physical activity
1year
Secondary Outcomes (2)
Determine bone mass (density) in hemophilia patients
1 yr
establish dose and duration of treatment with vitamin D
1 yr
Study Arms (1)
Hemophilia, Vitamin D deficiency
OTHER1. Hemophilia, Rickets - Vitamin D per endocrine consult 2. Hemophilia, Vitamin D deficient - Vitamin D 2000 units daily plus calcium 3. Hemophilia, Normal Vitamin D - no intervention - observation only
Interventions
Doses will be based on Vitamin D levels
Eligibility Criteria
You may qualify if:
- clinical diagnosis of Hemophilia A or B
- ages 2-21 years
You may not qualify if:
- therapeutic vitamin D or calcium supplementation within 3 months of study entry
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Virginia Commonwealth Universitylead
- CSL Behringcollaborator
Study Sites (1)
Virginia Commonwealth University Health System
Richmond, Virginia, 23298, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gita V Massey, M.D.
Virginia Commonwealth University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 16, 2010
First Posted
March 19, 2010
Study Start
March 1, 2010
Primary Completion
March 1, 2013
Study Completion
March 1, 2015
Last Updated
April 29, 2016
Record last verified: 2016-04